Kölner Wissenschaftlerinnen haben erstmals künstliche Nukleotide, die Bausteine der DNA, mit mehreren zusätzlichen Eigenschaften im Labor hergestellt, die künftig als künstliche Nukleinsäuren therapeutische Anwendungen finden können / Veröffentlichung im „Journal of the American Chemical Society“
from Pressemitteilungen – idw – Informationsdienst Wissenschaft https://ift.tt/ek9ZD2M
Martin Empting works towards the development of new active substances that can be used to treat bacterial and viral infections. He has now been awarded the Young Medicinal Chemist in Academia Prize by the European Federation of Medicinal Chemistry (EFMC) as a runner-up. This prize is aimed at young chemists who are pursuing a career in academic research.
Martin Empting works towards the development of new active substances that can be used to treat bacterial and viral infections. He has now been awarded the Young Medicinal Chemist in Academia Prize by the European Federation of Medicinal Chemistry (EFMC) as a runner-up. This prize is aimed at young chemists who are pursuing a career in academic research.